Our therapy areas

Unlocking the power of what science can do

The path to new treatments

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them.

Our most important therapeutic areas are Oncology; Cardiovascular, Renal and Metabolism; Respiratory & Immunology. We are also active in the fields of Gastroenterology; Infection and Vaccines; and Neuroscience.

Our therapy areas


Our ambition is to push the boundaries of science to provide therapies that further improve and extend the lives of patients living with cancer.

Cardiovascular, Renal and Metabolism (CVRM)

We aim to save the lives of people who suffer from cardiovascular disease, heart failure, chronic kidney disease and diabetes, by advancing CVRM solutions and addressing shared risk factors between these distinct but interrelated disease areas.

Respiratory & Immunology

We strive for scientific breakthroughs that change the treatment and life of patients with asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

Other disease areas

We have medicines and vaccines in other disease areas that have an important impact for patients. As such, we are selectively active in the areas of autoimmunity, infection & vaccines, neuroscience and gastroenterology, where we follow an opportunity-driven approach and often work through partnerships.

CH-4301; 06/2021